PFE Pfizer Inc (NYSE) -2.41% Jan 28 2026: Feb 3 earnings may change outlook

The most important fact is simple: PFE stock closed lower on Jan 28 2026 at $25.86, down -2.42%, as investors rotated ahead of Pfizer Inc.’s Feb 3 earnings. The company reports results on 2026-02-03 (08:30 ET), and guidance, margin details, and Paxlovid sales will drive near-term moves. Trading finished with volume of 44,250,370 shares as the Healthcare sector lagged. This earnings spotlight covers valuation, technicals, analyst tone, and Meyka AI model forecasts to prepare investors for the report